News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Longfellow Real Estate to Develop New 455,000 Square Foot Life Sciences Facility at Pennovation Works
Read about Penn's latest expansion within the innovation ecosystem.
Penn Engineering Graduates Develop a Device to Reduce Ocean Microplastic Pollution
Read about how May graduates won the 2022 President's Sustainability Prize for their device that reduces microplastic pollution.
CAR-T startup Vittoria Biotherapeutics launches
Vittoria Biotherapeutics' mission is to overcome current limitations of chimeric antigen receptor (CAR) T-cell therapeutics by using its unique cell engineering and gene editing technologies.
PCI highlights innovation in Penn Robotics during Philly Tech Week
From May 6 - 12, PCI participated in the 12th annual Philly Tech Week, a conference hosted by Technical.ly Philly, to showcase some of the city's best technology and innovation.
Abrax Japan licenses technology from Penn
Abrax Japan entered into an exclusive licensing agreement for certain Penn-owned inventions relating to the therapeutic effects of thymic stromal lymphopoietin (TSLP).
FY22 President’s Innovation Prizes Awarded
Awarded annually, the President’s Innovation Prize empowers Penn students to design and undertake a post-graduation startup company that makes a positive, lasting difference in the world.
New ASSET Center
Penn Engineering’s newly formed ASSET (AI-enabled Systems: Safety, Explainablity and Trustworthiness) Center is part of Penn Engineering’s Innovation in Data Engineering & Science (IDEAS) Initiative.
Austin Alumni host SXSW Pitch Program
For the 5th year, PCI partnered with the Penn Wharton Austin Alumni group to host a startup pitch session in conjunction with SXSW Interactive.
Cleantech innovation for CO2 capture moves forward through Heirloom Carbon Technologies
PCI, along with Columbia University and the University of British Columbia, recently completed a license agreement with Heirloom Carbon Technologies.
IBA partners with Penn Medicine to develop flash therapy
IBA Worldwide, a technology company that develops particle accelerator technology, partnered with a team of faculty from Radiation Oncology at Penn Medicine led by Dr. James Metz.